Takeda Pharmaceutical Co. Ltd. · TSE:4502

Plump Andrew Stewart sold 116,191 Takeda Pharmaceutical Co. Ltd. shares (Form 4)

Traded Sep 2, 2026 · Filed Sep 3, 2026

On Sep 2, 2026, Plump Andrew Stewart (Director, President, R&D) sold 116,191 Takeda Pharmaceutical Co. Ltd. shares at US$18.49 for US$2.15M under a trading plan, leaving 145,465 shares. Filed Sep 3, 2026 (Form 4).

Sold
116,191 shares
Price
US$18.49
Value
US$2.15M
Holding after
145,465 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026American Depositary SharesSale116,191US$18.49145,465Indirect

Source

View original at SEC

Related